Wenstrup, Jonathan http://orcid.org/0000-0001-9604-4638
Havtorn, Jakob Drachmann http://orcid.org/0000-0002-4849-0817
Borgholt, Lasse http://orcid.org/0000-0002-3562-8442
Blomberg, Stig Nikolaj
Maaloe, Lars http://orcid.org/0000-0003-2030-520X
Sayre, Michael R. http://orcid.org/0000-0003-0322-3181
Christensen, Hanne http://orcid.org/0000-0002-7472-3194
Kruuse, Christina
Christensen, Helle Collatz http://orcid.org/0000-0003-3302-7149
Funding for this research was provided by:
TrygFonden
Herlev Hospital
Københavns Universitet
Innovationsfonden (0153-00167B, 2051-00015B)
Novo Nordisk Fonden (NNF18OC0031840)
Article History
Received: 30 June 2023
Accepted: 29 November 2023
First Online: 19 December 2023
Competing interests
: J.D.H. and L.B. received funding from the Innovation Fund Denmark. J.D.H. and L.B. used Corti and held stock warrants. L.M. is a co-founder, stockholder, and the Chief Technology Officer of Corti. J.W. received funding from Trygfonden. S.N.F.B. has no conflicts of interest to declare. H.C. has received funding from the Velux Foundation, Tværsfonden, Helsefonden, Hartmann Fonden, Lundbeck Foundation, and Novo Nordisk Foundation; royalties from Gyldendal; honoraria from Bayer and Bristol Meyers Squibb, and is chair of Action Plan for stroke in Europe Implementation, Co-chair of the Scientific Stroke Panel EAN and Senior Guest Editor of AHA Stroke. M.S. has no conflicts of interest to declare. H.C.C. has no conflicts of interest to declare. C.K. received funding from the Novo Nordisk Foundation and is the chair of the Danish Resuscitation Council and vice chair of the Danish Stroke Society. Both positions are unpaid.